NewslettersCancer Stem Cell NewsUncategorizedTargeting CD123 in Hematologic Malignancies: Identifying Suitable Patients for Targeted TherapyBy Justin.choi - May 19, 2021026Scientists review the methodologies available for CD123 assessment and discuss the biological and clinical characteristics of patients for whom CD123-targeting therapies may have a clinical impact.[Leukemia & Lymphoma] 6445212 88KLACQY items 1 apa 0 default asc 1 162387 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract